bendamustine
Showing 26 - 50 of 173
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Leukemia
- Nemtabrutinib
- +7 more
- (no location specified)
Nov 30, 2022
Indolent Non-hodgkin Lymphoma Trial in München (Obinutuzumab, Bendamustine)
Active, not recruiting
- Indolent Non-hodgkin Lymphoma
- Obinutuzumab
- Bendamustine
-
München, Bavaria, GermanyKlinikum der Universität München
Jul 23, 2021
Hodgkin Lymphoma Trial (favezelimab/pembrolizumab, bendamustine, gemcitabine)
Not yet recruiting
- Hodgkin Lymphoma
- favezelimab/pembrolizumab
- +2 more
- (no location specified)
Aug 18, 2022
Relapsed, Refractory, Multiple Myeloma Trial in Guangzhou (Pomalidomide, Bendamustine, Dexamethasone)
Not yet recruiting
- Relapsed, Refractory, Multiple Myeloma
- Pomalidomide
- +2 more
-
Guangzhou, Please Select, ChinaSun Yat-sen University Cancer Center
Feb 17, 2021
Mantle Cell Lymphoma Trial in Boston (Rituximab, Bendamustine, Cytarabine)
Active, not recruiting
- Mantle Cell Lymphoma
- Rituximab
- +2 more
-
Boston, Massachusetts
- +2 more
Jun 9, 2021
Hodgkin's Lymphoma Trial in Poland (drug, diagnostic test, procedure)
Recruiting
- Hodgkin's Lymphoma
- Bendamustine
- +4 more
-
Bydgoszcz, Poland
- +12 more
Dec 23, 2021
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +5 more
- Rituximab
- +2 more
-
Providence, Rhode IslandRhode Island Hospital and The Miriam Hospital
Jul 19, 2021
Follicular Lymphoma (FL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)
Recruiting
- Follicular Lymphoma (FL)
- Odronextamab
- +6 more
-
Westbury, New YorkClinical Research Alliance Inc
Oct 13, 2023
Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)
Completed
- Lymphoma, Follicular
- Bendamustine
- +2 more
-
Scarborough, Maine
- +3 more
Apr 27, 2021
Lymphatic Diseases Trial in Italy (Brentuximab Vedotin, Bendamustine)
Terminated
- Lymphatic Diseases
- Brentuximab Vedotin
- Bendamustine
-
Bologna, BO, Italy
- +4 more
May 26, 2021
Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in United States (Duvelisib, Placebo,
Withdrawn
- Indolent Non-Hodgkin's Lymphoma
- +3 more
- Duvelisib
- +3 more
-
Plainville, Connecticut
- +6 more
Mar 15, 2021
Bendamustine, Multiple Myeloma Trial in Shenyang (Bendamustine)
Recruiting
- Bendamustine
- Multiple Myeloma
- Bendamustine
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Aug 7, 2021
Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Zanubrutinib)
Recruiting
- Chronic Lymphoid Leukemia
- Bendamustine
- +3 more
-
Aachen, Germany
- +20 more
Oct 5, 2021
Hematopoietic and Lymphoid System Tumor Trial in Houston (procedure, drug, biological, radiation)
Recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2022
Lymphoma, Lymphoma, B-Cell, Immune System Diseases Trial in Chapel Hill (iC9-CAR19 T cells, Bendamustine, Fludarabine)
Recruiting
- Lymphoma
- +4 more
- iC9-CAR19 T cells
- +4 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022
Hodgkin Lymphoma, Adult Trial in Chapel Hill (ATLCAR.CD30, Bendamustine, Fludarabine)
No longer available
- Hodgkin Lymphoma, Adult
- ATLCAR.CD30
- +2 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2021
Mantle Cell Lymphoma Trial in Worldwide (Bendamustine, Rituximab, Ibrutinib)
Active, not recruiting
- Mantle Cell Lymphoma
- Bendamustine
- +3 more
-
Tucson, Arizona
- +201 more
Jan 27, 2023
AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)
Not yet recruiting
- AL Amyloidosis
- Venetoclax Oral Tablet, 200 mg
- +9 more
-
New York, New YorkNew York Presbyterian Hospital/Columbia University Irving Medica
Jul 11, 2022
Peripheral T Cell Lymphoma Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 T cells, Bendamustine, Fludarabine)
Recruiting
- Peripheral T Cell Lymphoma
- ATLCAR.CD30 T cells
- +3 more
-
Chapel Hill, North Carolina
- +1 more
Mar 4, 2022
Relapsed/Refractory Follicular Lymphoma Trial in Nashville (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)
Recruiting
- Relapsed/Refractory Follicular Lymphoma
- Axicabtagene Ciloleucel
- +8 more
-
Denver, Colorado
- +6 more
Dec 2, 2022
Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia, Mixed-Lineage Acute Leukemias Trial in Saint-Petersburg (Allogeneic stem
Completed
- Leukemia, Acute Lymphoblastic
- +2 more
- Allogeneic stem cell transplantation
- +3 more
-
Saint-Petersburg, Russian FederationFirst Pavlov State Medical University of St. Petersburg
Nov 19, 2020